Mineralys Therapeutics Inc
XNAS: MLYS
Mineralys Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administere...
Read More
39.27
-0.60
(-1.50%)
2.5M
XNAS Volume
XNAS 19 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Mineralys Therapeutics Inc is on 30 Sep 2025 for the purpose of Stifel 2025 Virtual Cardiometabolic Forum
See details
Not Eligible
Expensive Valuation
Technically Bullish
Mineralys Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..